collection
https://read.qxmd.com/read/32652695/protek-duo-rapid-deployment-cannulation-utilized-to-bridge-to-durable-heartware-left-ventricular-assist-device
#21
Alexander D Ghannam, Ashok N Babu, Eric I Jeng
A 43-year-old gentleman was transferred for management of acute on chronic cardiogenic shock (left ventricular ejection fraction < 10%). Upon arrival, we inserted a left axillary intra-aortic balloon pump for hemodynamic support. He underwent an emergent left and right-heart catheterization which showed patent stents and coronaries, in the setting of severely elevated pulmonary artery and pulmonary capillary wedge pressure. On hospital day 35, we escalated support to Centrimag in conjunction with a 31 French Protek Duo Rapid Deployment cannula...
August 2020: Journal of Cardiac Surgery
https://read.qxmd.com/read/25674024/temporary-mechanical-circulatory-support-a-review-of-the-options-indications-and-outcomes
#22
REVIEW
Nisha A Gilotra, Gerin R Stevens
Cardiogenic shock remains a challenging disease entity and is associated with significant morbidity and mortality. Temporary mechanical circulatory support (MCS) can be implemented in an acute setting to stabilize acutely ill patients with cardiomyopathy in a variety of clinical situations. Currently, several options exist for temporary MCS. We review the indications, contraindications, clinical applications, and evidences for a variety of temporary circulatory support options, including the intra-aortic balloon pump (IABP), extracorporeal membrane oxygenation (ECMO), CentriMag blood pump, and percutaneous ventricular assist devices (pVADs), specifically the TandemHeart and Impella...
2014: Clinical Medicine Insights. Cardiology
https://read.qxmd.com/read/28472406/short-term-mechanical-circulatory-support-as-a-bridge-to-durable-left-ventricular-assist-device-implantation-in-refractory-cardiogenic-shock-a-systematic-review-and-meta-analysis
#23
REVIEW
Corstiaan A den Uil, Sakir Akin, Lucia S Jewbali, Dinis Dos Reis Miranda, Jasper J Brugts, Alina A Constantinescu, Arie Pieter Kappetein, Kadir Caliskan
Short-term mechanical circulatory support (MCS) is increasingly used as a bridge to decision in patients with refractory cardiogenic shock. Subsequently, these patients might be bridged to durable MCS either as a bridge to candidacy/transplantation, or as destination therapy. The aim of this study was to review support duration and clinical outcome of short-term MCS in cardiogenic shock, and to analyse application of this technology as a bridge to long-term cardiac support (left ventricular assist device, LVAD) from 2006 till June 2016...
July 1, 2017: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/28388392/cardiogenic-shock-from-ecmo-to-impella-and-beyond
#24
REVIEW
Mehdi H Shishehbor, Nader Moazami, Michael Zhen-Yu Tong, Shinya Unai, W H Wilson Tang, Edward G Soltesz
For patients in cardiogenic shock, several devices can serve as a "bridge," ie, provide circulatory support and allow the patient to live long enough to recover or to receive a heart transplant or a long-term device. Options include an intra-aortic balloon pump, TandemHeart, Impella, extracorporeal membrane oxygenation (ECMO), and CentriMag. Which device to use depends on individual patient needs, local expertise, and anatomic and physiologic considerations.
April 2017: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/29473181/bridging-to-a-long-term-ventricular-assist-device-with-short-term-mechanical-circulatory-support
#25
JOURNAL ARTICLE
Chitaru Kurihara, Masashi Kawabori, Tadahisa Sugiura, Andre C Critsinelis, Suwei Wang, William E Cohn, Andrew B Civitello, O H Frazier, Jeffrey A Morgan
Implanting short-term mechanical circulatory support (MCS) devices as a bridge-to-decision is increasingly popular. However, outcomes have not been well studied in patients who receive short-term MCS before receiving long-term left ventricular assist device (LVAD) support. We analyzed outcomes in our single-center experience with long-term continuous-flow (CF)-LVAD recipients with pre-implantation short-term MCS. From November 2003 through March 2016, 526 patients (mean age, 54.7 ± 13.5 years) with chronic heart failure (mean ejection fraction, 21...
June 2018: Artificial Organs
https://read.qxmd.com/read/30187234/a-systematic-review-of-effectiveness-and-economic-evaluation-of-cardiohelp-and-portable-devices-for-extracorporeal-membrane-oxygenation-ecmo
#26
JOURNAL ARTICLE
Alireza Mahboub-Ahari, Fariba Heidari, Fatemeh Sadeghi-Ghyassi, Maryam Asadi
In recent years, there have been substantial advancements in the development of different technologies for extracorporeal membrane oxygenation (ECMO) for in-hospital and out of hospital applications. However the effectiveness of these devices is not clearly known. The objective of this study was to evaluate the cost-effectiveness of Cardiohelp compared to other portable ECMO devices. In this systematic review, we searched Medline (via Ovid), Embase, Pubmed, Cochrane Library, SCOPUS, CRD and NICE. Articles were assessed by two independent reviewers for eligibility and quality of the evidence...
March 2019: Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs
https://read.qxmd.com/read/30266366/short-term-circulatory-and-right-ventricle-support-in-cardiogenic-shock-extracorporeal-membrane-oxygenation-tandem-heart-centrimag-and-impella
#27
REVIEW
Ibrahim Sultan, Arman Kilic, Ahmet Kilic
Severe right ventricular (RV) failure is a significant cause of morbidity and mortality, with an in-hospital mortality rate up to 70% to 75%. Medical management is employed and is successful for most of these patients. However, a small percentage of patients will continue to have persistent RV failure, for which mechanical support is used for management.
October 2018: Heart Failure Clinics
https://read.qxmd.com/read/30807379/adverse-event-profile-associated-with-prolonged-use-of-centrimag-ventricular-assist-device-for-refractory-cardiogenic-shock
#28
JOURNAL ARTICLE
Marisa R Cevasco, Boyangzi Li, Jiho Han, Codruta Chiuzan, Christine M Mauro, Paul Kurlansky, A Reshad Garan, Koji Takeda, Yoshifumi Naka, Hiroo Takayama
Several studies have investigated early outcomes with a surgical short-term ventricular assist device (VAD), but little is known about adverse event profile during prolonged support with a surgical short-term VAD. This is a retrospective analysis of 161 patients who received a CentriMag ventricular assist system (Abbott Laboratories, Abbott Park, IL) at our institution between January 2007 and June 2014. Device-related adverse events include major bleeding, infection, and stroke incidents occurring during CentriMag support...
2019: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
https://read.qxmd.com/read/29956563/unique-static-discharge-events-on-two-centrimag-%C3%A2-2-nd-gen-ecmo-patients-causing-console-failure
#29
JOURNAL ARTICLE
Robert K Wise, Sherry M Waldhausen, Van T Nguyen, David A Palanzo, Larry D Baer
The use of ECMO for cardiovascular support continues to increase in the United States and around the world. It is not a benign endeavor as serious complications may occur. We present our experience of two second generation CentriMag® (Abbott formerly Thoratec Inc.) console failures that occurred while transporting the patients to other areas of the hospital. In each incident, the patients were immediately placed on back-up units and the transport continued. No patient complications could be attributed to the failures...
November 2018: Perfusion
https://read.qxmd.com/read/27184945/short-term-ventricular-assist-device-as-a-bridge-to-decision-in-cardiogenic-shock-is-it-a-justified-strategy
#30
JOURNAL ARTICLE
Mohamed Zeriouh, Prashant Mohite, Binu Raj, Anton Sabashnikov, Javid Fatullayev, Diana Garcia Saez, Bartrlomiej Zych, Ali Ghodsizad, Parwis Rahmanian, Yeong-Hoon Choi, Thorsten Wahlers, Andre R Simon, Aron F Popov, Achim Koch
PURPOSE: Low cardiac output syndrome is associated with significant mortality. In patients with refractory low cardiac output left ventricular assist devices (VAD) are used to re-establish cardiac output and to prevent death. However, long-term LVAD implantation in these is complicated by a high rate of right heart failure and mortality. Therefore, our strategy is to implant a short-term VAD (left or biventricular) as a bridge to decission. METHODS: We retrospectively analysed data from 66 patients who received a short-term LVAD support prior to implantation of a long-term LVAD or HTx between 2003 and 2014...
May 16, 2016: International Journal of Artificial Organs
https://read.qxmd.com/read/24667583/the-cost-impact-of-short-term-ventricular-assist-devices-and-extracorporeal-life-support-systems-therapies-on-the-national-health-service-in-the-uk
#31
COMPARATIVE STUDY
Oleg Borisenko, Gillian Wylie, John Payne, Staffan Bjessmo, Jon Smith, Richard Firmin, Nizar Yonan
OBJECTIVES: The objective of the study was to assess the cost of using different blood pumps for short-term ventricular assist device (VAD) and extracorporeal life support (ECLS) systems for cardiac and cardiorespiratory failure in the UK. METHODS: The cost analysis presented was based on evaluation of the time required to provide circulatory support for the following indications: post-cardiac surgery cardiogenic shock, postacute myocardial infarction cardiogenic shock, deteriorating end-stage heart failure (ESHF) and the ability of different blood pumps to provide support for the necessary duration...
July 2014: Interactive Cardiovascular and Thoracic Surgery
https://read.qxmd.com/read/25027874/bridge-to-decision-therapy-with-a-continuous-flow-external-ventricular-assist-device-in-refractory-cardiogenic-shock-of-various-causes
#32
COMPARATIVE STUDY
Hiroo Takayama, Lori Soni, Bindu Kalesan, Lauren K Truby, Takeyoshi Ota, Sophia Cedola, Zain Khalpey, Nir Uriel, Paolo Colombo, Donna M Mancini, Ulrich P Jorde, Yoshifumi Naka
BACKGROUND: Mortality for refractory cardiogenic shock remains high. In this patient cohort, there have been mixed results in mechanical circulatory support device use as a bridge-to-decision therapy. We evaluated a continuous-flow external ventricular assist device (VAD), CentriMag VAD (Thoratec Corp., Pleasanton, CA), in patients with various causes of refractory cardiogenic shock. METHODS AND RESULTS: This is a retrospective review of adult patients who underwent surgical CentriMag VAD insertion as bridge-to-decision therapy...
September 2014: Circulation. Heart Failure
https://read.qxmd.com/read/20212070/mechanical-performance-comparison-between-rotaflow-and-centrimag-centrifugal-blood-pumps-in-an-adult-ecls-model
#33
COMPARATIVE STUDY
Yulong Guan, Xiaowei Su, Robert McCoach, Allen Kunselman, Aly El-Banayosy, Akif Undar
INTRODUCTION: Centrifugal blood pumps have been widely adopted in conventional adult cardiopulmonary bypass and circulatory assist procedures. Different brands of centrifugal blood pumps incorporate distinct designs which affect pump performance. In this adult extracorporeal life support (ECLS) model, the performances of two brands of centrifugal blood pump (RotaFlow blood pump and CentriMag blood pump) were compared. METHODS: The simulated adult ECLS circuit used in this study included a centrifugal blood pump, Quadrox D membrane oxygenator and Sorin adult ECLS tubing package...
March 2010: Perfusion
https://read.qxmd.com/read/25524992/survival-on-biventricular-mechanical-support-with-the-centrimag%C3%A2-as-a-bridge-to-decision-a-single-center-risk-stratification
#34
JOURNAL ARTICLE
B Mohamedali, G Bhat, G Yost, A Tatooles
OBJECTIVE: Temporary mechanical assist devices are increasingly being used as a lifesaving bridge to decision in patients requiring cardiopulmonary resuscitation. We report our single-center experience with biventricular Centrimag® pumps over a five-year period. METHOD: Data was retrospectively collected in consecutive patients who required biventricular support from 2008 to 2013. Patients who were supported with central cannulation using the Centrimag® system were analyzed...
April 2015: Perfusion
https://read.qxmd.com/read/25010916/thoratec-centrimag-for-temporary-treatment-of-refractory-cardiogenic-shock-or-severe-cardiopulmonary-insufficiency-a-systematic-literature-review-and-meta-analysis-of-observational-studies
#35
REVIEW
Oleg Borisenko, Gillian Wylie, John Payne, Staffan Bjessmo, Jon Smith, Nizar Yonan, Richard Firmin
The aim of the study was to systematically evaluate effect of CentriMag heart pump (Thoratec Corporation) as temporary ventricular assist device (VAD) and part of extracorporeal membrane oxygenation (ECMO) system on outcomes in patients with cardiac or cardiac-respiratory failure. A systematic search was conducted in five databases for the period 2003 to 2012. Fifty-three publications with data for 999 patients, supported with CentriMag, were included. In 72% studies, CentriMag was used as a VAD and in 25% as part of ECMO circuit...
2014: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
https://read.qxmd.com/read/27256069/physical-therapist-led-ambulatory-rehabilitation-for-patients-receiving-centrimag-short-term-ventricular-assist-device-support-retrospective-case-series
#36
JOURNAL ARTICLE
Laura McGarrigle, Jennifer Caunt
BACKGROUND AND PURPOSE: Short-term ventricular assist device (VAD) support is used in the intensive care unit (ICU) to support individuals in end-stage heart failure prior to heart transplantation or implantation of a long-term left VAD. The literature investigating the feasibility, safety, and content of rehabilitation for this patient group is lacking. This report retrospectively describes the rehabilitation strategy, safety measures used, and nature of any adverse events and, therefore, the feasibility of this practice...
December 2016: Physical Therapy
https://read.qxmd.com/read/27211964/skirted-cannula-technique-for-apical-cannulation-in-implantation-of-centrimag-left-ventricular-assist-device
#37
JOURNAL ARTICLE
Ta-Chung Shen, Kuei-Ton Tsai, Chin-Yuan Hu, Robert Jeen-Chen Chen
The CentriMag, an extracorporeal short-term ventricular assist device designed for treatment of patients with acute cardiogenic shock, is Conformité Européenne-marked in Europe for use up to 30 days. Extended use beyond the licensed period is not uncommon, however. We have developed a skirted cannula technique for apical cannulation in implantation of the Centrimag. This technique allows easy positioning of the cannula and excellent hemostasis. It also offers secure fixation of the cannula so that patients can ambulate and attend rehabilitation programs should extended use be anticipated...
June 2016: Annals of Thoracic Surgery
https://read.qxmd.com/read/27818380/novel-minimally-invasive-surgical-approach-using-an-external-ventricular-assist-device-and-extracorporeal-membrane-oxygenation-in-refractory-cardiogenic-shock
#38
JOURNAL ARTICLE
Koji Takeda, Arthur R Garan, Veli K Topkara, Ajay J Kirtane, Dimitri Karmpaliotis, Paul Kurlansky, Melana Yuzefpolskaya, Paolo C Colombo, Yoshifumi Naka, Hiroo Takayama
Objectives: The use of short-term mechanical circulatory support (MCS) has increased in the treatment of refractory cardiogenic shock (RCS). Percutaneous short-term MCS technology has emerged rapidly; however, limitations in flow and durability remain. We therefore investigated a minimally invasive surgical approach using an external ventricular assist device (VAD) and extracorporeal membrane oxygenation (ECMO) in patients with RCS. Methods: Twenty-five patients underwent minimally invasive external VAD insertion with a magnetically levitated centrifugal pump for various causes of cardiogenic shock between April 2010 and May 2016...
March 1, 2017: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/27122879/prolonged-use-of-levitronix-left-ventricular-assist-device-as-a-bridge-to-heart-transplantation
#39
Shih-Ying Sung, Po-Shun Hsu, Jia-Lin Chen, Chien-Sung Tsai, Yi-Ting Tsai, Chih-Yuan Lin, Chung-Yi Lee, Hong-Yan Ke, Yi-Chang Lin
UNLABELLED: A 61-year-old male presented to our emergency room with chest tightness, dyspnea, and cold sweat. He underwent a 12-lead EKG which showed ST-elevation from leads V1-V4 and T wave inversion in leads II, III, and aVF. His troponin-I level was elevated to 70.3 ng/ml. He went into cardiogenic shock when he was in the catheter room. After advanced cardiac life support was administered for 30 min, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) cannulation was set up using 21-french arterial and 21-french venous cannula through the right femoral artery and right femoral vein by the puncture method for hemodynamic support...
May 2015: Acta Cardiologica Sinica
https://read.qxmd.com/read/26115147/a-technique-for-implantation-of-the-centrimag-left-ventricular-assist-device-to-allow-ambulation-and-rehabilitation-in-patients-with-heart-failure
#40
JOURNAL ARTICLE
Curt Tribble, Miguel Urencio, Giorgio Aru, Walter Merrill
BACKGROUND: The therapeutic options for heart failure include inotropic agents, intraaortic balloon pumps, and left ventricular assist devices (LVAD). Implantable LVADs are not appropriate for all patients. The short-term devices require patients to stay in bed, connected to cannulas, which are usually inserted using a median sternotomy. This approach requires a subsequent sternotomy, midline cannulas (which can make sitting difficult), and immobility. We began using a right thoracotomy with cannulas placed through intercostal spaces for selected patients in need of temporary LVAD support...
June 26, 2015: Heart Surgery Forum
label_collection
label_collection
4507
2
3
2015-11-15 20:57:46
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.